Patterns of Diabetes Care Among People with Type 1 Diabetes During Ramadan: An International Prospective Study (DAR-MENA T1DM)
Autor: | Naim Shehadeh, Monira Al Arouj, Faris Abdul Kareem Khazaal, Cecile Dessapt-Baradez, Khier Djaballah, Akram Echtay, Khaled El Sayed El Hadidy, Abdulrahman Al Shaikh, Mohamed Hassanein, Mohamad Omar Abu-Hijleh, Mohamed El Hassan Gharbi, Sobia Sabir Ali, Abdullah Bennakhi, Fatheya F. Al Awadi |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2020 |
Předmět: |
Adult
Male 030213 general clinical medicine Pediatrics medicine.medical_specialty Epidemiology Population Hypoglycemia Islam Diabetes Complications 03 medical and health sciences 0302 clinical medicine Patient Education as Topic Diabetes mellitus Medicine Type 1 diabetes Humans Hypoglycemic Agents Pharmacology (medical) Prospective Studies education Prospective cohort study Original Research education.field_of_study Ramadan business.industry Incidence (epidemiology) Incidence General Medicine Fasting Middle Aged medicine.disease Adaptation Physiological Diabetes Mellitus Type 1 Diabetes Mellitus Type 2 030220 oncology & carcinogenesis Hyperglycemia Observational study Female business |
Zdroj: | Advances in Therapy |
ISSN: | 1865-8652 0741-238X |
Popis: | Introduction To describe the characteristics and care of participants with type 1 diabetes during Ramadan in the Middle East and North Africa. Methods The DAR-MENA (Diabetes and Ramadan—Middle East and North Africa) study was a prospective, observational study of adults with type 1 and type 2 diabetes who were Muslim and did/did not intend to fast during Ramadan 2016. Baseline data were collected 6 weeks prior to Ramadan, with a follow-up visit 1–2 months after Ramadan. This is the analysis of the population with type 1 diabetes. Measurements included proportion who fasted, reasons for fasting and not fasting, changes in diabetes treatment, hypoglycemic events, and proportion with access to diabetes education. Results Of 136 participants with type 1 diabetes, 76.9% (100/130) fasted for at least 1 day, 72.3% (94/130) fasted for at least 15 days, and 48.5% (63/130) fasted for 30 days. The majority (63.0%, 63/100) reported personal decision as a reason to fast. Fear of diabetic complications (58.6%, 17/29) and previous complications related to fasting (48.3%, 14/29) were the most common reasons for not fasting. Adjustment of diabetic medication regimen occurred for 84.6% (115/136) of participants, and 72.8% (99/136) changed their treatment dose. The incidence and number of adverse events for confirmed and severe hypoglycemia were similar before and during Ramadan. Almost half of participants had access to diabetes education (45.6%, 62/136). Conclusion The DAR-MENA study showed that despite the risks associated with fasting for people with type 1 diabetes, almost half fasted for the full 30 days of Ramadan with no significant change in hypoglycemia events. Since the current International Diabetes Federation and Diabetes and Ramadan guidelines do not endorse fasting for people with type 1 diabetes, it is important that those who insist on fasting work closely with their healthcare practitioner to avoid any complications. Electronic Supplementary Material The online version of this article (10.1007/s12325-020-01267-4) contains supplementary material, which is available to authorized users. |
Databáze: | OpenAIRE |
Externí odkaz: |